首页> 外文期刊>Biologicals: Journal of the International Association of Biological Standardization >Stability of live attenuated classical swine fever cell culture vaccine virus in liquid form for developing an oral vaccine
【24h】

Stability of live attenuated classical swine fever cell culture vaccine virus in liquid form for developing an oral vaccine

机译:液体形式的现场病变古典猪瘟细胞培养疫苗病毒的稳定性,用于开发口腔疫苗

获取原文
获取原文并翻译 | 示例
           

摘要

Classical swine fever (CSF) is an important viral disease of pigs and controlled by vaccination. Unorganised backyard and wild pigs are difficult to vaccinate by needle vaccination. Here we formulated liquid vaccines using an Indian CSF cell culture vaccine virus and four stabilisers and evaluated their stability at 4 degrees C, 25 degrees C and 37 degrees C up to 24 h for use as oral vaccine. The stabilisers were Lactalbumin hydrolysate-Trehalose, Lactalbumin hydmlysate-Trehalose-Gelatin, Lactalbumin hydrolysate-Lactose-Sucrose and Lactalbumin hydrolysate-Sucrose. The liquid vaccines, with or without stabilisers, were stable at 4 degrees C up to 24 h, whereas, a drop of one logio titre was observed at 25 degrees C during the same period. At 37 degrees C, the virus titre diminished by only one logio with the Lactalbumin hydrolysate-Trehalose (LT) stabiliser up to 24 h compared to two log(10) losses in virus titre with other stabilisers and virus control. We therefore conclude that for developing a CSF oral vaccine, the vaccine virus in liquid form can be used directly during the winter, whereas for developing the oral vaccine for summer, the LT stabiliser would provide maximum stability to the virus to withstand the warm temperature while maintaining adequate therapeutic titre for inducing a protective immune response.
机译:猪瘟(CSF)是一种重要的猪病毒性疾病,通过疫苗接种控制。无组织的后院和野猪很难通过针头疫苗接种。在这里,我们使用印度脑脊液细胞培养疫苗病毒和四种稳定剂配制了液体疫苗,并评估了它们在4摄氏度、25摄氏度和37摄氏度下24小时内作为口服疫苗的稳定性。稳定剂为乳清蛋白水解海藻糖、乳清蛋白水解海藻糖明胶、乳清蛋白水解乳糖蔗糖和乳清蛋白水解蔗糖。液体疫苗,无论有没有稳定剂,在4摄氏度到24小时内都是稳定的,而在同一时期,在25摄氏度下观察到一个logio滴度下降。在37摄氏度时,使用乳清蛋白水解物海藻糖(LT)稳定剂的病毒滴度在24小时内仅下降一个对数,而使用其他稳定剂和病毒控制的病毒滴度下降两个对数(10)。因此,我们得出结论,在研制CSF口服疫苗时,液体形式的疫苗病毒可在冬季直接使用,而在研制夏季口服疫苗时,LT稳定剂将为病毒提供最大的稳定性,以抵抗高温,同时保持足够的治疗滴度,以诱导保护性免疫反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号